首页> 外国专利> EARLY DIAGNOSTIC TECHNIQUE FOR EBOLA HEMORRHAGIC FEVER IN INDIVIDUALS PRESUMABLY INFECTED WITH SUCH VIRUS

EARLY DIAGNOSTIC TECHNIQUE FOR EBOLA HEMORRHAGIC FEVER IN INDIVIDUALS PRESUMABLY INFECTED WITH SUCH VIRUS

机译:预先感染这种病毒的个体的埃博拉出血热的早期诊断技术

摘要

FIELD: medicine.;SUBSTANCE: blood serum is sampled from individuals presumably infected with such virus for the first time in 3-4 hours and for the second time - in 15-18 hours after presumed infection. Each serum sample is examined for a level of hemolytic complement activity (HCA) by any known technique. If observing the HCA in 1.5-2.0 times and more for a specified period of time, the fact of body infection is stated, and the absence or minor change of the HCA shows the absence of body infection. The HCA level can be evaluated by unified technique showing intact sheep erythrocyte lysis with commercial hemolytic anti-sheep rabbit serum.;EFFECT: use of the technique enables earlier diagnosing of Ebola hemorrhagic fever that will allow prescribing a complete complex of therapeutic actions immediately.;2 cl, 1 tbl, 4 dwg
机译:领域:药物;物质:从估计感染这种病毒的个体中,在3-4小时内第一次采样血清,第二次-在估计感染后15-18小时内,第二次采样。通过任何已知技术检查每个血清样品的溶血补体活性(HCA)水平。如果在指定的时间段内以1.5-2.0倍或更多的时间观察HCA,则表明存在身体感染的事实,并且HCA的缺乏或微小变化表明没有身体感染。可以通过统一技术评估HCA水平,该技术显示完整的羊红细胞与市售溶血性抗绵羊兔血清一起裂解。 2厘升,1汤匙,4载重吨

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号